help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeda, A.
Right arrow Articles by Masliah, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeda, A.
Right arrow Articles by Masliah, E.

American Journal of Pathology, Vol 152, 367-372, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders

A Takeda, M Mallory, M Sundsmo, W Honer, L Hansen and E Masliah
Department of Neurosciences, University of California, San Diego, School of Medicine La Jolla, 92093-0624, USA.

The precursor of the non-Abeta component of Alzheimer's disease amyloid (NACP) (also known as a-synuclein) is a presynaptic terminal molecule that accumulates in the plaques of Alzheimer's disease. Recent studies have shown that a mutation in NACP is associated with familial Parkinson's disease, and that Lewy bodies are immunoreactive with antibodies against this molecule. To clarify the patterns of accumulation and differences in abnormal compartmentalization, we studied NACP immunoreactivity using double immunolabeling and laser scanning confocal microscopy in the cortex of patients with various neurodegenerative disorders. In Lewy body variant of Alzheimer's disease, diffuse Lewy body disease, and Parkinson's disease, NACP was found to immunolabel cortical Lewy bodies, abnormal neurites, and dystrophic neurites in the plaques. Double-labeling studies showed that all three of these neuropathological structures also contained ubiquitin, synaptophysin, and neurofilament (but not tau) immunoreactivity. In contrast, neurofibrillary tangles, neuropil threads, Pick bodies, ballooned neurons, and glial tangles (most of which were tau positive) were NACP negative. These results support the view that NACP specifically accumulates in diseases related to Lewy bodies such as Lewy body variant of Alzheimer's disease, diffuse Lewy body disease, and Parkinson's disease and suggests a role for this synaptic protein in the pathogenesis of neurodegeneration.


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
L. Crews, H. Mizuno, P. Desplats, E. Rockenstein, A. Adame, C. Patrick, B. Winner, J. Winkler, and E. Masliah
{alpha}-Synuclein Alters Notch-1 Expression and Neurogenesis in Mouse Embryonic Stem Cells and in the Hippocampus of Transgenic Mice
J. Neurosci., April 16, 2008; 28(16): 4250 - 4260.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Kawahara, M. Hashimoto, P. Bar-On, G. J. Ho, L. Crews, H. Mizuno, E. Rockenstein, S. Z. Imam, and E. Masliah
{alpha}-Synuclein Aggregates Interfere with Parkin Solubility and Distribution: ROLE IN THE PATHOGENESIS OF PARKINSON DISEASE
J. Biol. Chem., March 14, 2008; 283(11): 6979 - 6987.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wei, M. Fujita, M. Nakai, M. Waragai, K. Watabe, H. Akatsu, E. Rockenstein, E. Masliah, and M. Hashimoto
Enhanced Lysosomal Pathology Caused by beta-Synuclein Mutants Linked to Dementia with Lewy Bodies
J. Biol. Chem., September 28, 2007; 282(39): 28904 - 28914.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Eyal, R. Szargel, E. Avraham, E. Liani, J. Haskin, R. Rott, and S. Engelender
Synphilin-1A: An aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from {alpha}-synucleinopathy patients
PNAS, April 11, 2006; 103(15): 5917 - 5922.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. W. Shults
Lewy bodies
PNAS, February 7, 2006; 103(6): 1661 - 1668.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. W. Shults, E. Rockenstein, L. Crews, A. Adame, M. Mante, G. Larrea, M. Hashimoto, D. Song, T. Iwatsubo, K. Tsuboi, et al.
Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human {alpha}-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy
J. Neurosci., November 16, 2005; 25(46): 10689 - 10699.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Liu, W. Liu, Y. Wu, Y. Zhou, R. Xue, C. Luo, L. Wang, W. Zhao, J.-D. Jiang, and J. Liu
Loss of Epigenetic Control of Synuclein-{gamma} Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers
Cancer Res., September 1, 2005; 65(17): 7635 - 7643.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. H. Norris, B. I. Giasson, R. Hodara, S. Xu, J. Q. Trojanowski, H. Ischiropoulos, and V. M.-Y. Lee
Reversible Inhibition of {alpha}-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations
J. Biol. Chem., June 3, 2005; 280(22): 21212 - 21219.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Zhong, Y. Tan, A. Zhou, Q. Yu, and J. Zhou
RING Finger Ubiquitin-Protein Isopeptide Ligase Nrdp1/FLRF Regulates Parkin Stability and Activity
J. Biol. Chem., March 11, 2005; 280(10): 9425 - 9430.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. A. Greenbaum, C. L. Graves, A. J. Mishizen-Eberz, M. A. Lupoli, D. R. Lynch, S. W. Englander, P. H. Axelsen, and B. I. Giasson
The E46K Mutation in {alpha}-Synuclein Increases Amyloid Fibril Formation
J. Biol. Chem., March 4, 2005; 280(9): 7800 - 7807.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Martin-Clemente, B. Alvarez-Castelao, I. Mayo, A. B. Sierra, V. Diaz, M. Milan, I. Farinas, T. Gomez-Isla, I. Ferrer, and J. G. Castano
{alpha}-Synuclein Expression Levels Do Not Significantly Affect Proteasome Function and Expression in Mice and Stably Transfected PC12 Cell Lines
J. Biol. Chem., December 17, 2004; 279(51): 52984 - 52990.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Jiang, Y. E. Liu, I. D. Goldberg, and Y. E. Shi
{gamma} Synuclein, a Novel Heat-Shock Protein-Associated Chaperone, Stimulates Ligand-Dependent Estrogen Receptor {alpha} Signaling and Mammary Tumorigenesis
Cancer Res., July 1, 2004; 64(13): 4539 - 4546.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. SIDHU, C. WERSINGER, and P. VERNIER
Does {alpha}-synuclein modulate dopaminergic synaptic content and tone at the synapse?
FASEB J, April 1, 2004; 18(6): 637 - 647.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Yanagawa, G. Tamura, T. Honda, M. Endoh, S. Nishizuka, and T. Motoyama
Demethylation of the Synuclein {gamma} Gene CpG Island in Primary Gastric Cancers and Gastric Cancer Cell Lines
Clin. Cancer Res., April 1, 2004; 10(7): 2447 - 2451.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Sawada, R. Kohno, T. Kihara, Y. Izumi, N. Sakka, M. Ibi, M. Nakanishi, T. Nakamizo, K. Yamakawa, H. Shibasaki, et al.
Proteasome Mediates Dopaminergic Neuronal Degeneration, and Its Inhibition Causes {alpha}-Synuclein Inclusions
J. Biol. Chem., March 12, 2004; 279(11): 10710 - 10719.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Necula, C. N. Chirita, and J. Kuret
Rapid Anionic Micelle-mediated {alpha}-Synuclein Fibrillization in Vitro
J. Biol. Chem., November 21, 2003; 278(47): 46674 - 46680.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. A. da Costa, E. Masliah, and F. Checler
{beta}-Synuclein Displays an Antiapoptotic p53-dependent Phenotype and Protects Neurons from 6-Hydroxydopamine-induced Caspase 3 Activation: CROSS-TALK WITH {alpha}-SYNUCLEIN AND IMPLICATION FOR PARKINSON'S DISEASE
J. Biol. Chem., September 26, 2003; 278(39): 37330 - 37335.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. Wu, Z. Weng, Q. Tao, G. Lin, X. Wu, H. Qian, Y. Zhang, X. Ding, Y. Jiang, and Y. E. Shi
Stage-specific Expression of Breast Cancer-specific Gene {gamma}-Synuclein
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 920 - 925.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Jiang, Y. E. Liu, A. Lu, A. Gupta, I. D. Goldberg, J. Liu, and Y. E. Shi
Stimulation of Estrogen Receptor Signaling by {gamma} Synuclein
Cancer Res., July 15, 2003; 63(14): 3899 - 3903.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
C Colosimo, A J Hughes, L Kilford, and A J Lees
Lewy body cortical involvement may not always predict dementia in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 852 - 856.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. M. Sampathu, B. I. Giasson, A. C. Pawlyk, J. Q. Trojanowski, and V. M.-Y. Lee
Ubiquitination of {alpha}-Synuclein Is Not Required for Formation of Pathological Inclusions in {alpha}-Synucleinopathies
Am. J. Pathol., July 1, 2003; 163(1): 91 - 100.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
H. ISCHIROPOULOS
Oxidative Modifications of {alpha}-Synuclein
Ann. N.Y. Acad. Sci., June 1, 2003; 991(1): 93 - 100.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. HASHIMOTO, E. ROCKENSTEIN, and E. MASLIAH
Transgenic Models of {alpha}-Synuclein Pathology: Past, Present, and Future
Ann. N.Y. Acad. Sci., June 1, 2003; 991(1): 171 - 188.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. M. Park, H. Y. Jung, H. O. Kim, H. Rhim, S. R. Paik, K. C. Chung, J. H. Park, and J. Kim
Evidence that alpha -synuclein functions as a negative regulator of Ca++-dependent alpha -granule release from human platelets
Blood, September 18, 2002; 100(7): 2506 - 2514.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
Y.-H. Suh and F. Checler
Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease
Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. Kirik, C. Rosenblad, C. Burger, C. Lundberg, T. E. Johansen, N. Muzyczka, R. J. Mandel, and A. Bjorklund
Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of alpha -Synuclein in the Nigrostriatal System
J. Neurosci., April 1, 2002; 22(7): 2780 - 2791.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. N. Uversky, J. Li, P. Souillac, I. S. Millett, S. Doniach, R. Jakes, M. Goedert, and A. L. Fink
Biophysical Properties of the Synucleins and Their Propensities to Fibrillate. INHIBITION OF alpha -SYNUCLEIN ASSEMBLY BY beta - AND gamma -SYNUCLEINS
J. Biol. Chem., March 29, 2002; 277(14): 11970 - 11978.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Hashimoto, L. J. Hsu, E. Rockenstein, T. Takenouchi, M. Mallory, and E. Masliah
alpha -Synuclein Protects against Oxidative Stress via Inactivation of the c-Jun N-terminal Kinase Stress-signaling Pathway in Neuronal Cells
J. Biol. Chem., March 22, 2002; 277(13): 11465 - 11472.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. J. Kahle, M. Neumann, L. Ozmen, V. Muller, S. Odoy, N. Okamoto, H. Jacobsen, T. Iwatsubo, J. Q. Trojanowski, H. Takahashi, et al.
Selective Insolubility of {alpha}-Synuclein in Human Lewy Body Diseases Is Recapitulated in a Transgenic Mouse Model
Am. J. Pathol., December 1, 2001; 159(6): 2215 - 2225.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Masliah, E. Rockenstein, I. Veinbergs, Y. Sagara, M. Mallory, M. Hashimoto, and L. Mucke
beta -Amyloid peptides enhance alpha -synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
PNAS, September 19, 2001; (2001) 211412398.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. Sharma, J. Hewett, L. J. Ozelius, V. Ramesh, P. J. McLean, X. O. Breakefield, and B. T. Hyman
A Close Association of TorsinA and {{alpha}}-Synuclein in Lewy Bodies : A Fluorescence Resonance Energy Transfer Study
Am. J. Pathol., July 1, 2001; 159(1): 339 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. G. SPILLANTINI and M. GOEDERT
The {alpha}-Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy
Ann. N.Y. Acad. Sci., December 1, 2000; 920(1): 16 - 27.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. J. Kahle, M. Neumann, L. Ozmen, V. Muller, H. Jacobsen, A. Schindzielorz, M. Okochi, U. Leimer, H. van der Putten, A. Probst, et al.
Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant alpha -Synuclein in Human and Transgenic Mouse Brain
J. Neurosci., September 1, 2000; 20(17): 6365 - 6373.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H. van der Putten, K.-H. Wiederhold, A. Probst, S. Barbieri, C. Mistl, S. Danner, S. Kauffmann, K. Hofele, W. P. J. M. Spooren, M. A. Ruegg, et al.
Neuropathology in Mice Expressing Human alpha -Synuclein
J. Neurosci., August 15, 2000; 20(16): 6021 - 6029.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. J. Hsu, Y. Sagara, A. Arroyo, E. Rockenstein, A. Sisk, M. Mallory, J. Wong, T. Takenouchi, M. Hashimoto, and E. Masliah
{alpha}-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Am. J. Pathol., August 1, 2000; 157(2): 401 - 410.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M. Shoji, Y. Harigaya, A. Sasaki, K. Uéda, K. Ishiguro, E. Matsubara, M. Watanabe, M. Ikeda, M. Kanai, Y. Tomidokoro, et al.
Accumulation of NACP/alpha -synuclein in Lewy body disease and multiple system atrophy
J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 605 - 608.
[Abstract] [Full Text]

Home page
 Ann. N. Y. Acad. Sci.Home page
P. GRAMMAS, U. REIMANN-PHILIPP, and P. H. WEIGEL
Cerebrovasculature-mediated Neuronal Cell Death
Ann. N.Y. Acad. Sci., April 1, 2000; 903(1): 55 - 60.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
E. Masliah, E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, A. Takeda, Y. Sagara, A. Sisk, and L. Mucke
Dopaminergic Loss and Inclusion Body Formation in -Synuclein Mice: Implications for Neurodegenerative Disorders
Science, February 18, 2000; 287(5456): 1265 - 1269.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
N. Canu, C. Barbato, M. T. Ciotti, A. Serafino, L. Dus, and P. Calissano
Proteasome Involvement and Accumulation of Ubiquitinated Proteins in Cerebellar Granule Neurons Undergoing Apoptosis
J. Neurosci., January 15, 2000; 20(2): 589 - 599.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Okochi, J. Walter, A. Koyama, S. Nakajo, M. Baba, T. Iwatsubo, L. Meijer, P. J. Kahle, and C. Haass
Constitutive Phosphorylation of the Parkinson's Disease Associated alpha -Synuclein
J. Biol. Chem., January 7, 2000; 275(1): 390 - 397.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. D. Kaytor and S. T. Warren
Aberrant Protein Deposition and Neurological Disease
J. Biol. Chem., December 31, 1999; 274(53): 37507 - 37510.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Hashimoto, A. Takeda, L. J. Hsu, T. Takenouchi, and E. Masliah
Role of Cytochrome c as a Stimulator of alpha -Synuclein Aggregation in Lewy Body Disease
J. Biol. Chem., October 8, 1999; 274(41): 28849 - 28852.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
E. Gomez-Tortosa, K. Newell, M. C. Irizarry, M. Albert, J. H. Growdon, and B. T. Hyman
Clinical and quantitative pathologic correlates of dementia with Lewy bodies
Neurology, October 1, 1999; 53(6): 1284 - 1284.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
J. G. Culvenor, C. A. McLean, S. Cutt, B. C. V. Campbell, F. Maher, P. Jakala, T. Hartmann, K. Beyreuther, C. L. Masters, and Q.-X. Li
Non-A{beta} Component of Alzheimer's Disease Amyloid (NAC) Revisited : NAC and {alpha}-Synuclein Are Not Associated with A{beta} Amyloid
Am. J. Pathol., October 1, 1999; 155(4): 1173 - 1181.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. W. Dickson, W.-K. Liu, J. Hardy, M. Farrer, N. Mehta, R. Uitti, M. Mark, T. Zimmerman, L. Golbe, J. Sage, et al.
Widespread Alterations of {alpha}-Synuclein in Multiple System Atrophy
Am. J. Pathol., October 1, 1999; 155(4): 1241 - 1251.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. Ostrerova, L. Petrucelli, M. Farrer, N. Mehta, P. Choi, J. Hardy, and B. Wolozin
alpha -Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins
J. Neurosci., July 15, 1999; 19(14): 5782 - 5791.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Narhi, S. J. Wood, S. Steavenson, Y. Jiang, G. M. Wu, D. Anafi, S. A. Kaufman, F. Martin, K. Sitney, P. Denis, et al.
Both Familial Parkinson's Disease Mutations Accelerate alpha -Synuclein Aggregation
J. Biol. Chem., April 2, 1999; 274(14): 9843 - 9846.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. I. Giasson, K. Uryu, J. Q. Trojanowski, and V. M.-Y Lee
Mutant and Wild Type Human alpha -Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro
J. Biol. Chem., March 19, 1999; 274(12): 7619 - 7622.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
V. L. Buchman, H. J. A. Hunter, L. G. P. Pinon, J. Thompson, E. M. Privalova, N. N. Ninkina, and A. M. Davies
Persyn, a Member of the Synuclein Family, Has a Distinct Pattern of Expression in the Developing Nervous System
J. Neurosci., November 15, 1998; 18(22): 9335 - 9341.
[Abstract] [Full Text] [PDF]

Home page
 AM J ALZHEIMERS DIS OTHER DEMENHome page
E. Gomez-Tortosa, K. Newell, M. Irizarry, and B. T. Hyman
Clinical and neuropathological features of dementia with Lewy bodies
American Journal of Alzheimer's Disease and Other Dementias, November 1, 1998; 13(6): 284 - 290.
[Abstract] [PDF]

Home page
 Genome Res.Home page
C. Lavedan
The Synuclein Family
Genome Res., September 1, 1998; 8(9): 871 - 880.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. G. Spillantini, R. A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert
alpha -Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
PNAS, May 26, 1998; 95(11): 6469 - 6473.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Souza, B. I. Giasson, Q. Chen, V. M.-Y. Lee, and H. Ischiropoulos
Dityrosine Cross-linking Promotes Formation of Stable alpha -Synuclein Polymers. IMPLICATION OF NITRATIVE AND OXIDATIVE STRESS IN THE PATHOGENESIS OF NEURODEGENERATIVE SYNUCLEINOPATHIES
J. Biol. Chem., June 9, 2000; 275(24): 18344 - 18349.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Jo, J. McLaurin, C. M. Yip, P. St. George-Hyslop, and P. E. Fraser
alpha -Synuclein Membrane Interactions and Lipid Specificity
J. Biol. Chem., October 27, 2000; 275(44): 34328 - 34334.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. I. Giasson, I. V. J. Murray, J. Q. Trojanowski, and V. M.-Y. Lee
A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of alpha -Synuclein Is Essential for Filament Assembly
J. Biol. Chem., January 19, 2001; 276(4): 2380 - 2386.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. A. Alim, M. S. Hossain, K. Arima, K. Takeda, Y. Izumiyama, M. Nakamura, H. Kaji, T. Shinoda, S. Hisanaga, and K. Ueda
Tubulin Seeds alpha -Synuclein Fibril Formation
J. Biol. Chem., January 11, 2002; 277(3): 2112 - 2117.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Masliah, E. Rockenstein, I. Veinbergs, Y. Sagara, M. Mallory, M. Hashimoto, and L. Mucke
beta -Amyloid peptides enhance alpha -synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
PNAS, October 9, 2001; 98(21): 12245 - 12250.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.